JPMORGAN CHASE & CO - HILLEVAX INC ownership

HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 62 filers reported holding HILLEVAX INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$295,201
-3.1%
21,948
+23.9%
0.00%
Q2 2023$304,590
+23.8%
17,719
+18.8%
0.00%
Q1 2023$246,000
+129373.7%
14,909
+31.4%
0.00%
Q4 2022$190
-99.8%
11,348
+60.2%
0.00%
Q3 2022$121,000
+59.2%
7,082
+2.2%
0.00%
Q2 2022$76,0006,9290.00%
Other shareholders
HILLEVAX INC shareholders Q1 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$7,517,5149.98%
Frazier Life Sciences Management, L.P. 9,781,472$131,560,7988.74%
Samsara BioCapital, LLC 799,274$10,750,2353.29%
VR Adviser, LLC 2,037,313$27,401,8602.88%
StepStone Group LP 826,567$11,117,3262.48%
ACUTA CAPITAL PARTNERS, LLC 270,319$3,635,7912.44%
Deep Track Capital, LP 2,900,000$39,005,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,004,231$53,856,9071.19%
Carlyle Group Inc. 1,838,486$24,690,8671.07%
Monashee Investment Management LLC 110,000$1,479,5000.62%
View complete list of HILLEVAX INC shareholders